<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628873</url>
  </required_header>
  <id_info>
    <org_study_id>Lindheim2015-01</org_study_id>
    <nct_id>NCT02628873</nct_id>
  </id_info>
  <brief_title>Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement</brief_title>
  <acronym>HyCoSy</acronym>
  <official_title>Can Contrast Infused Sonography Using Air Bubbles Replace Hysterosalpingogram as the Diagnostic Evaluation of Fallopian Tube Patency Following Hysteroscopic Sterilization Using Essure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wright State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wright State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates whether saline infused sonography (SIS) with directed air bubbles for&#xD;
      hysterosalpingo-contrast sonography (HyCoSy) is as good as or better than X-ray&#xD;
      hysterosalpingography (HSG) for determining whether fallopian tubes are open or closed in&#xD;
      patients who are undergoing an Essure confirmation test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The gold standard for evaluating whether fallopian tubes are open versus closed is the X-ray&#xD;
      hysterosalpingography (HSG). HSG is a radiologic procedure that is performed to verify that&#xD;
      placement of the Essure tubal ligation inserts have successfully blocked the fallopian tubes.&#xD;
      However, this procedure involved exposure to radiation. The saline infused sonography (SIS)&#xD;
      with directed air bubbles for hysterosalpingo-contrast sonography (HyCoSy) does not involve&#xD;
      radiation and can be done in a physician's office. The HyCoSy air bubble device may be a&#xD;
      lower cost, safer alternative procedure if it can be shown to provide similar results for&#xD;
      tubal patency.&#xD;
&#xD;
      This study will compare the HyCoSy procedure results with the HSG procedure results in women&#xD;
      who require the HSG procedure after receiving Essure tubal ligation inserts for their Essure&#xD;
      confirmation test.&#xD;
&#xD;
      Women will be randomized to receive the HycoSy procedure first, followed by the HSG procedure&#xD;
      or to the reverse order. Two independent readers will review the video results for both&#xD;
      procedures to determine the degree of agreement on tubal patency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Essure no longer sold in the US after Dec 2018; Sponsor requested trial be ended&#xD;
  </why_stopped>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Cross over study in which participants receive one diagnostic test (SSI or HSG), then receive the other.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes assessor does not know which procedure was received first or second.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fallopian Tube Patency - HyCoSy vs HSG</measure>
    <time_frame>At time of procedure</time_frame>
    <description>Observed flow of fluid/bubbles through fallopian tubes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>At time of procedures</time_frame>
    <description>Patient reported pain scale score on visual pain scale (rated 0 for no pain to 10 for severe pain with corresponding faces)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician Evaluation of Uterine Cavity</measure>
    <time_frame>At time of HyCoSy procedure</time_frame>
    <description>Observed image of uterus (normal or not normal). Assessor commented on uterine cavity to determine whether cavity was normal versus abnormal, e.g., bicornuate uterus or any notable uterine deformity. Data were coded as &quot;normal' or &quot;not normal&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Arm 1 (HyCoSy followed by HSG)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HyCoSy procedure followed by HSG procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 (HSG followed by HyCoSy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HSG procedure followed by HyCoSy procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HyCoSy</intervention_name>
    <description>Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
    <arm_group_label>Arm 1 (HyCoSy followed by HSG)</arm_group_label>
    <arm_group_label>Arm 2 (HSG followed by HyCoSy)</arm_group_label>
    <other_name>Fem Vue</other_name>
    <other_name>Saline Air Device</other_name>
    <other_name>Saline infused sonogram</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Documentation of normal Pap smear within 1 year prior to enrollment into study.&#xD;
&#xD;
          -  Written informed consent given&#xD;
&#xD;
          -  Need for evaluation of tubal status for post-Essure tubal occlusion&#xD;
&#xD;
          -  Negative urine pregnancy test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of unresolved dysfunctional uterine bleeding (DUB).&#xD;
&#xD;
          -  History of a hysterectomy.&#xD;
&#xD;
          -  Current urogenital disease.&#xD;
&#xD;
          -  History of allergic response to IVP dye (exclusion for HSG).&#xD;
&#xD;
          -  Abnormal pap smear.&#xD;
&#xD;
          -  Positive urine pregnancy test.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Lindheim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wright State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wright State Physicians</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Smith RD. Contemporary hysteroscopic methods for female sterilization. Int J Gynaecol Obstet. 2010 Jan;108(1):79-84. doi: 10.1016/j.ijgo.2009.07.026. Review.</citation>
    <PMID>19716128</PMID>
  </reference>
  <reference>
    <citation>Practice Committee of the American Society for Reproductive Medicine. Optimal evaluation of the infertile female. Fertil Steril. 2006 Nov;86(5 Suppl 1):S264-7. Review.</citation>
    <PMID>17055838</PMID>
  </reference>
  <reference>
    <citation>Radić V, Canić T, Valetić J, Duić Z. Advantages and disadvantages of hysterosonosalpingography in the assessment of the reproductive status of uterine cavity and fallopian tubes. Eur J Radiol. 2005 Feb;53(2):268-73.</citation>
    <PMID>15664291</PMID>
  </reference>
  <reference>
    <citation>Veersema S, Vleugels MP, Moolenaar LM, Janssen CA, Brölmann HA. Unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril. 2010 Jan;93(1):35-8. doi: 10.1016/j.fertnstert.2008.10.005. Epub 2008 Nov 21.</citation>
    <PMID>19027109</PMID>
  </reference>
  <reference>
    <citation>The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988 Jun;49(6):944-55.</citation>
    <PMID>3371491</PMID>
  </reference>
  <reference>
    <citation>Okonofua FE, Essen UI, Nimalaraj T. Hysterosalpingography versus laparoscopy in tubal infertility: comparison based on findings at laparatomy. Int J Gynaecol Obstet. 1989 Feb;28(2):143-7.</citation>
    <PMID>2563701</PMID>
  </reference>
  <reference>
    <citation>Musich JR, Behrman SJ. Infertility laparoscopy in perspective: review of five hundred cases. Am J Obstet Gynecol. 1982 Jun 1;143(3):293-303.</citation>
    <PMID>6211097</PMID>
  </reference>
  <reference>
    <citation>al-Badawi IA, Fluker MR, Bebbington MW. Diagnostic laparoscopy in infertile women with normal hysterosalpingograms. J Reprod Med. 1999 Nov;44(11):953-7.</citation>
    <PMID>10589406</PMID>
  </reference>
  <reference>
    <citation>Romano F, Cicinelli E, Anastasio PS, Epifani S, Fanelli F, Galantino P. Sonohysterography versus hysteroscopy for diagnosing endouterine abnormalities in fertile women. Int J Gynaecol Obstet. 1994 Jun;45(3):253-60.</citation>
    <PMID>7926245</PMID>
  </reference>
  <reference>
    <citation>Nannini R, Chelo E, Branconi F, Tantini C, Scarselli GF. Dynamic echohysteroscopy: a new diagnostic technique in the study of female infertility. Acta Eur Fertil. 1981 Jun;12(2):165-71.</citation>
    <PMID>7293673</PMID>
  </reference>
  <reference>
    <citation>Parsons AK, Lense JJ. Sonohysterography for endometrial abnormalities: preliminary results. J Clin Ultrasound. 1993 Feb;21(2):87-95.</citation>
    <PMID>8381140</PMID>
  </reference>
  <reference>
    <citation>Lindheim SR, Adsuar N, Kushner DM, Pritts EA, Olive DL. Sonohysterography: a valuable tool in evaluating the female pelvis. Obstet Gynecol Surv. 2003 Nov;58(11):770-84.</citation>
    <PMID>14581828</PMID>
  </reference>
  <reference>
    <citation>Mitri FF, Andronikou AD, Perpinyal S, Hofmeyr GJ, Sonnendecker EW. A clinical comparison of sonographic hydrotubation and hysterosalpingography. Br J Obstet Gynaecol. 1991 Oct;98(10):1031-6.</citation>
    <PMID>1751435</PMID>
  </reference>
  <reference>
    <citation>Richman TS, Viscomi GN, deCherney A, Polan ML, Alcebo LO. Fallopian tubal patency assessed by ultrasound following fluid injection. Work in progress. Radiology. 1984 Aug;152(2):507-10.</citation>
    <PMID>6539931</PMID>
  </reference>
  <reference>
    <citation>Session DR, Lerner JP, Tchen CK, Kelly AC. Ultrasound-guided fallopian tube cannulation using Albunex. Fertil Steril. 1997 May;67(5):972-4.</citation>
    <PMID>9130913</PMID>
  </reference>
  <reference>
    <citation>Campbell S, Bourne TH, Tan SL, Collins WP. Hysterosalpingo contrast sonography (HyCoSy) and its future role within the investigation of infertility in Europe. Ultrasound Obstet Gynecol. 1994 May 1;4(3):245-53.</citation>
    <PMID>12797192</PMID>
  </reference>
  <reference>
    <citation>Luciano DE, Exacoustos C, Johns DA, Luciano AA. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients? Am J Obstet Gynecol. 2011 Jan;204(1):79.e1-5. doi: 10.1016/j.ajog.2010.08.065.</citation>
    <PMID>21187197</PMID>
  </reference>
  <reference>
    <citation>Emanuel MH, van Vliet M, Weber M, Exalto N. First experiences with hysterosalpingo-foam sonography (HyFoSy) for office tubal patency testing. Hum Reprod. 2012 Jan;27(1):114-7. doi: 10.1093/humrep/der367. Epub 2011 Nov 6.</citation>
    <PMID>22064649</PMID>
  </reference>
  <reference>
    <citation>Holz K, Becker R, Schürmann R. Ultrasound in the investigation of tubal patency. A meta-analysis of three comparative studies of Echovist-200 including 1007 women. Zentralbl Gynakol. 1997;119(8):366-73.</citation>
    <PMID>9286072</PMID>
  </reference>
  <reference>
    <citation>Andersen AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod. 1994 Oct;9(10):1935-8.</citation>
    <PMID>7844229</PMID>
  </reference>
  <reference>
    <citation>Strandell A, Bourne T, Bergh C, Granberg S, Asztely M, Thorburn J. The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients. Ultrasound Obstet Gynecol. 1999 Sep;14(3):200-4.</citation>
    <PMID>10550881</PMID>
  </reference>
  <reference>
    <citation>Stumpf PG, March CM. Febrile morbidity following hysterosalpingography: identification of risk factors and recommendations for prophylaxis. Fertil Steril. 1980 May;33(5):487-92.</citation>
    <PMID>7371880</PMID>
  </reference>
  <reference>
    <citation>Moore DE, Segars JH Jr, Winfield AC, Page DL, Eisenberg AD, Holburn GE. Effects of contrast agents on the fallopian tube in a rabbit model. Radiology. 1990 Sep;176(3):721-4.</citation>
    <PMID>2167499</PMID>
  </reference>
  <reference>
    <citation>Thurmond AS, Hedgpeth PL, Scanlan RM. Selective injection of contrast media: inflammatory effects on rabbit fallopian tubes. Radiology. 1991 Jul;180(1):97-9.</citation>
    <PMID>1647040</PMID>
  </reference>
  <reference>
    <citation>Lindequist S, Justesen P, Larsen C, Rasmussen F. Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. Radiology. 1991 Apr;179(1):69-74.</citation>
    <PMID>1848715</PMID>
  </reference>
  <reference>
    <citation>Acton CM, Devitt JM, Ryan EA. Hysterosalpingography in infertility--an experience of 3,631 examinations. Aust N Z J Obstet Gynaecol. 1988 May;28(2):127-33. Review.</citation>
    <PMID>2976272</PMID>
  </reference>
  <reference>
    <citation>Mohiyiddeen L, Hardiman A, Fitzgerald C, Hughes E, Mol BW, Johnson N, Watson A. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2015 May 1;(5):CD003718. doi: 10.1002/14651858.CD003718.pub4. Review. Update in: Cochrane Database Syst Rev. 2020 Oct 15;10:CD003718.</citation>
    <PMID>25929235</PMID>
  </reference>
  <reference>
    <citation>Boyer P, Territo MC, de Ziegler D, Meldrum DR. Ethiodol inhibits phagocytosis by pelvic peritoneal macrophages. Fertil Steril. 1986 Oct;46(4):715-7.</citation>
    <PMID>3019786</PMID>
  </reference>
  <reference>
    <citation>Johnson JV, Montoya IA, Olive DL. Ethiodol oil contrast medium inhibits macrophage phagocytosis and adherence by altering membrane electronegativity and microviscosity. Fertil Steril. 1992 Sep;58(3):511-7.</citation>
    <PMID>1325928</PMID>
  </reference>
  <reference>
    <citation>Darby SC, Wall BF. The genetically significant dose from diagnostic radiology in Great Britain. Radiography. 1981 Sep;47(561):200-2.</citation>
    <PMID>7330172</PMID>
  </reference>
  <reference>
    <citation>Karande VC, Pratt DE, Balin MS, Levrant SG, Morris RS, Gleicher N. What is the radiation exposure to patients during a gynecoradiologic procedure? Fertil Steril. 1997 Feb;67(2):401-3.</citation>
    <PMID>9022623</PMID>
  </reference>
  <reference>
    <citation>Volpi E, Zuccaro G, Patriarca A, Rustichelli S, Sismondi P. Transvaginal sonographic tubal patency testing using air and saline solution as contrast media in a routine infertility clinic setting. Ultrasound Obstet Gynecol. 1996 Jan;7(1):43-8.</citation>
    <PMID>8932631</PMID>
  </reference>
  <reference>
    <citation>Swart P, Mol BW, van der Veen F, van Beurden M, Redekop WK, Bossuyt PM. The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril. 1995 Sep;64(3):486-91.</citation>
    <PMID>7641899</PMID>
  </reference>
  <reference>
    <citation>Sulak PJ, Letterie GS, Coddington CC, Hayslip CC, Woodward JE, Klein TA. Histology of proximal tubal occlusion. Fertil Steril. 1987 Sep;48(3):437-40.</citation>
    <PMID>2957237</PMID>
  </reference>
  <reference>
    <citation>Hamed HO, Shahin AY, Elsamman AM. Hysterosalpingo-contrast sonography versus radiographic hysterosalpingography in the evaluation of tubal patency. Int J Gynaecol Obstet. 2009 Jun;105(3):215-7. doi: 10.1016/j.ijgo.2009.02.001. Epub 2009 Mar 31.</citation>
    <PMID>19339010</PMID>
  </reference>
  <reference>
    <citation>Chenia F, Hofmeyr GJ, Moolla S, Oratis P. Sonographic hydrotubation using agitated saline: a new technique for improving fallopian tube visualization. Br J Radiol. 1997 Aug;70(836):833-6.</citation>
    <PMID>9486049</PMID>
  </reference>
  <reference>
    <citation>Exacoustos C, Zupi E, Carusotti C, Lanzi G, Marconi D, Arduini D. Hysterosalpingo-contrast sonography compared with hysterosalpingography and laparoscopic dye pertubation to evaluate tubal patency. J Am Assoc Gynecol Laparosc. 2003 Aug;10(3):367-72.</citation>
    <PMID>14567814</PMID>
  </reference>
  <reference>
    <citation>Kiyokawa K, Masuda H, Fuyuki T, Koseki M, Uchida N, Fukuda T, Amemiya K, Shouka K, Suzuki K. Three-dimensional hysterosalpingo-contrast sonography (3D-HyCoSy) as an outpatient procedure to assess infertile women: a pilot study. Ultrasound Obstet Gynecol. 2000 Dec;16(7):648-54.</citation>
    <PMID>11169373</PMID>
  </reference>
  <reference>
    <citation>Deichert U, Schleif R, van de Sandt M, Juhnke I. Transvaginal hysterosalpingo-contrast-sonography (Hy-Co-Sy) compared with conventional tubal diagnostics. Hum Reprod. 1989 May;4(4):418-24.</citation>
    <PMID>2526153</PMID>
  </reference>
  <reference>
    <citation>Degenhardt F, Jibril S, Eisenhauer B. Hysterosalpingo-contrast sonography (HyCoSy) for determining tubal patency. Clin Radiol. 1996 Feb;51 Suppl 1:15-8.</citation>
    <PMID>8605765</PMID>
  </reference>
  <reference>
    <citation>Patel MD, Acord DL, Young SW. Likelihood ratio of sonographic findings in discriminating hydrosalpinx from other adnexal masses. AJR Am J Roentgenol. 2006 Apr;186(4):1033-8.</citation>
    <PMID>16554575</PMID>
  </reference>
  <reference>
    <citation>Reis MM, Soares SR, Cancado ML, Camargos AF. Hysterosalpingo contrast sonography (HyCoSy) with SH U 454 (Echovist) for the assessment of tubal patency. Hum Reprod. 1998 Nov;13(11):3049-52.</citation>
    <PMID>9853854</PMID>
  </reference>
  <reference>
    <citation>Tanawattanacharoen S, Suwajanakorn S, Uerpairojkit B, Boonkasemsanti W, Virutamasen P. Transvaginal hysterosalpingo-contrast sonography (HyCoSy) compared with chromolaparoscopy. J Obstet Gynaecol Res. 2000 Feb;26(1):71-5.</citation>
    <PMID>10761336</PMID>
  </reference>
  <reference>
    <citation>Shi WT, Forsberg F, Bautista R, Vecchio C, Bernardi R, Goldberg BB. Image enhancement by acoustic conditioning of ultrasound contrast agents. Ultrasound Med Biol. 2004 Feb;30(2):191-8.</citation>
    <PMID>14998671</PMID>
  </reference>
  <reference>
    <citation>Connor V. Contrast infusion sonography in the post-Essure setting. J Minim Invasive Gynecol. 2008 Jan-Feb;15(1):56-61. doi: 10.1016/j.jmig.2007.07.008.</citation>
    <PMID>18262145</PMID>
  </reference>
  <reference>
    <citation>Hurd WW, Wyckoff ET, Reynolds DB, Amesse LS, Gruber JS, Horowitz GM. Patient rotation and resolution of unilateral cornual obstruction during hysterosalpingography. Obstet Gynecol. 2003 Jun;101(6):1275-8.</citation>
    <PMID>12798536</PMID>
  </reference>
  <reference>
    <citation>Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF, Fromm R, Quinones MA, Zoghbi WA. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009 Mar 3;53(9):802-10. doi: 10.1016/j.jacc.2009.01.005.</citation>
    <PMID>19245974</PMID>
  </reference>
  <reference>
    <citation>Hamilton JA, Larson AJ, Lower AM, Hasnain S, Grudzinskas JG. Evaluation of the performance of hysterosalpingo contrast sonography in 500 consecutive, unselected, infertile women. Hum Reprod. 1998 Jun;13(6):1519-26.</citation>
    <PMID>9688385</PMID>
  </reference>
  <reference>
    <citation>Lanzani C, Savasi V, Leone FPG, Ratti M, Ferrazzi E. Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program. Fertil Steril. 2009 Sep;92(3):1158-1161. doi: 10.1016/j.fertnstert.2008.07.1746. Epub 2008 Oct 1.</citation>
    <PMID>18829020</PMID>
  </reference>
  <reference>
    <citation>Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med. 2000 Aug;19(8):519-27.</citation>
    <PMID>10944037</PMID>
  </reference>
  <results_reference>
    <citation>Luong E, Ludwin A, Winter T, Yaklic J, Maxwell RA, Bhagavath B, Lindheim SR. Saline-Air Hysterosalpingo-Contrast Sonography Is Equivalent to the Modified Hysterosalpingogram Following Hysteroscopic Sterilization. Ultrasound Q. 2020 Jun;36(2):138-145. doi: 10.1097/RUQ.0000000000000488.</citation>
    <PMID>32511207</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>October 5, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <results_first_submitted>December 13, 2019</results_first_submitted>
  <results_first_submitted_qc>August 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 31, 2020</results_first_posted>
  <last_update_submitted>August 22, 2020</last_update_submitted>
  <last_update_submitted_qc>August 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wright State University</investigator_affiliation>
    <investigator_full_name>Steven Lindheim, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>HSG</keyword>
  <keyword>HyCoSy</keyword>
  <keyword>Contraception</keyword>
  <keyword>Essure</keyword>
  <keyword>Saline Infused sonography</keyword>
  <keyword>SIS</keyword>
  <keyword>Air bubbles</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plans to share date due to small sample size</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 19, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT02628873/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from existing practice and clinic patients who had the Essure device placed for contraception.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1 (HyCoSy Followed by HSG)</title>
          <description>HyCoSy followed by HSG&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 (HSG Followed by HyCoSy)</title>
          <description>HSG followed by HyCoSy&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Test (1 Hour)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Break (1 Hour)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Test (1 Hour)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Number of participants are those who completed all assessments.&#xD;
Units of analysis for evaluation of the diagnostic tests is # fallopian tubes (open versus closed). All participants had 2 fallopian tubes.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1 (HyCoSy Followed by HSG)</title>
          <description>HyCoSy procedure followed by HSG procedure&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
        <group group_id="B2">
          <title>Arm 2 (HSG Followed by HyCoSy)</title>
          <description>HSG procedure followed by HyCoSy procedure&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units># fallopian tubes</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="38"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="13"/>
                <count group_id="B2" value="6"/>
                <count group_id="B3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units># fallopian tubes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="26"/>
                <count group_id="B2" value="12"/>
                <count group_id="B3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.9" spread="6.7"/>
                    <measurement group_id="B2" value="36.5" spread="6.7"/>
                    <measurement group_id="B3" value="37.3" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="13"/>
                <count group_id="B2" value="6"/>
                <count group_id="B3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units># fallopian tubes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="26"/>
                <count group_id="B2" value="12"/>
                <count group_id="B3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="0"/>
                <count group_id="B2" value="0"/>
                <count group_id="B3" value="0"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units># fallopian tubes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="26"/>
                <count group_id="B2" value="12"/>
                <count group_id="B3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="13"/>
                <count group_id="B2" value="6"/>
                <count group_id="B3" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units># fallopian tubes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="26"/>
                <count group_id="B2" value="12"/>
                <count group_id="B3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fallopian Tube Patency - HyCoSy vs HSG</title>
        <description>Observed flow of fluid/bubbles through fallopian tubes.</description>
        <time_frame>At time of procedure</time_frame>
        <population>Analysis was per fallopian tube.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 (HyCoSy Followed by HSG)</title>
            <description>HyCoSy procedure followed by HSG procedure</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 (HSG Followed by HyCoSy)</title>
            <description>HSG procedure followed by HyCoSy procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Fallopian Tube Patency - HyCoSy vs HSG</title>
          <description>Observed flow of fluid/bubbles through fallopian tubes.</description>
          <population>Analysis was per fallopian tube.</population>
          <units>fallopian tubes observed to be closed</units>
          <param>Count of Units</param>
          <units_analyzed>fallopian tubes observed to be closed</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>fallopian tubes observed to be closed</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of tubes closed per first procedure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of tubes closed per second procedure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Degree of agreement between the 2 Assessors</non_inferiority_desc>
            <p_value>&lt; 0.01</p_value>
            <method>Kappa</method>
            <param_type>Degree of agreement / Kappa</param_type>
            <param_value>0.48</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores</title>
        <description>Patient reported pain scale score on visual pain scale (rated 0 for no pain to 10 for severe pain with corresponding faces)</description>
        <time_frame>At time of procedures</time_frame>
        <population>Change in patient reported pain scores (pre-procedure minus post-procedure pain scores)</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 (HyCoSy Followed by HSG)</title>
            <description>HyCoSy procedure followed by HSG procedure</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 (HSG Followed by HyCoSy)</title>
            <description>HSG procedure followed by HyCoSy procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores</title>
          <description>Patient reported pain scale score on visual pain scale (rated 0 for no pain to 10 for severe pain with corresponding faces)</description>
          <population>Change in patient reported pain scores (pre-procedure minus post-procedure pain scores)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HSG post procedure pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="2.1"/>
                    <measurement group_id="O2" value="1.8" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HyCoSy post procedure pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="3.1"/>
                    <measurement group_id="O2" value="2.3" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>T-test to determine whether one method had greater reported pain</non_inferiority_desc>
            <p_value>&lt; 0.30</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.925</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.71</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.69</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physician Evaluation of Uterine Cavity</title>
        <description>Observed image of uterus (normal or not normal). Assessor commented on uterine cavity to determine whether cavity was normal versus abnormal, e.g., bicornuate uterus or any notable uterine deformity. Data were coded as &quot;normal' or &quot;not normal&quot;.</description>
        <time_frame>At time of HyCoSy procedure</time_frame>
        <population>Number of uteri assessed as 'normal'</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 (HyCoSy Followed by HSG)</title>
            <description>HyCoSy procedure followed by HSG procedure</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 (HSG Followed by HyCoSy)</title>
            <description>HSG procedure followed by HyCoSy procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Physician Evaluation of Uterine Cavity</title>
          <description>Observed image of uterus (normal or not normal). Assessor commented on uterine cavity to determine whether cavity was normal versus abnormal, e.g., bicornuate uterus or any notable uterine deformity. Data were coded as &quot;normal' or &quot;not normal&quot;.</description>
          <population>Number of uteri assessed as 'normal'</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt; 0.67</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test (pre-procedure versus post-procedure)</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>- 0.431</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.76</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>- 2.40</ci_lower_limit>
            <ci_upper_limit>1.56</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 week after procedures</time_frame>
      <group_list>
        <group group_id="E1">
          <title>HyCoSy Followed by HSG</title>
          <description>HyCoSy followed by HSG&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes&#xD;
followed by:&#xD;
HSG performed to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
        <group group_id="E2">
          <title>Hysterosalpingogram (HSG) Followed by HyCoSy</title>
          <description>Hysterosalpingogram (HSG) followed by HyCoSy&#xD;
HSG performed to evaluate the patency (openness) of the fallopian tubes&#xD;
followed by:&#xD;
HyCoSy: Saline infused sonogram in which air bubbles are delivered via the FemVue saline air device in order to evaluate the patency (openness) of the fallopian tubes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steven Lindheim</name_or_title>
      <organization>Wright State University</organization>
      <phone>858-740-1083</phone>
      <email>doclalalindheim@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

